John Mohr

Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications

Katherine H. Luepke, Katie J. Suda, Helen W. Boucher et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2016 · 348 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureus

John Mohr, Barbara E. Murray · Clinical Infectious Diseases · 2007 · 184 citations

Medicine, Pharmacology, Pharmacotherapy +17

Prospective Survey of (1→3)-β- <scp>d</scp> -Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

John Mohr, Charles R. Sims, Victor L. Paetznick et al. · Journal of Clinical Microbiology · 2010 · 107 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Community-associated Methicillin-resistant<i>Staphylococcus aureus</i>in Pediatric Patients

Theresa J. Ochoa, John Mohr, Audrey Wanger et al. · Emerging infectious diseases · 2005 · 105 citations · Full text

Life Sciences, Microbiology, Pediatrics +15

A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

John Mohr, Peggy S. McKinnon, Patti J. Peymann et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2005 · 88 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +14